The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Efficacy of regorafenib (REG) in patients with hepatocellular carcinoma (HCC) in the phase III RESORCE trial according to alpha-fetoprotein (AFP) and c-Met levels as predictors of poor prognosis.

Michael  Teufel

Employment - Bayer

Stock and Other Ownership Interests  - Bayer

Karl  Köchert

Employment - Bayer

Gerold  Meinhardt

Employment - Bayer

Stock and Other Ownership Interests  - Bayer

Jordi  Bruix

Consulting or Advisory Role - Abbvie; ArQule; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; BTG; Gilead Sciences; Kowa; Novartis; Onxeo; OSI Pharmaceuticals; Roche; TERUMO

Research Funding - Bayer